Cabaletta Bio Inc [CABA] stock prices are up 10.80% to $4.72 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CABA shares have gain 8.01% over the last week, with a monthly amount drifted -18.48%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cabaletta Bio Inc [NASDAQ: CABA] stock has seen the most recent analyst activity on February 05, 2024, when Jefferies initiated its Buy rating and assigned the stock a price target of $36. Previously, William Blair started tracking the stock with Outperform rating on November 29, 2023, and set its price target to $38. On October 24, 2023, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $40 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $31 on October 19, 2023. Citigroup initiated its recommendation with a Buy and recommended $22 as its price target on September 05, 2023. Guggenheim started tracking with a Buy rating for this stock on July 18, 2023, and assigned it a price target of $34. In a note dated January 27, 2023, Morgan Stanley upgraded an Overweight rating on this stock and boosted its target price from $3 to $16.
The stock price of Cabaletta Bio Inc [CABA] has been fluctuating between $3.47 and $26.35 over the past year. Currently, Wall Street analysts expect the stock to reach $16.33 within the next 12 months. Cabaletta Bio Inc [NASDAQ: CABA] shares were valued at $4.72 at the most recent close of the market. An investor can expect a potential return of 245.97% based on the average CABA price forecast.
Analyzing the CABA fundamentals
Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at -24.97%, Pretax Profit Margin comes in at -22.44%, and Net Profit Margin reading is -22.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.44 and Total Capital is -0.5. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.34 points at the first support level, and at 3.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.94, and for the 2nd resistance point, it is at 5.15.
Ratios To Look Out For
It’s worth pointing out that Cabaletta Bio Inc [NASDAQ:CABA]’s Current Ratio is 11.52. Also, the Quick Ratio is 11.52, while the Cash Ratio stands at 9.98.
Transactions by insiders
Recent insider trading involved Binder Gwendolyn, that happened on Jan 19 ’24 when 11000.0 shares were sold., Binder Gwendolyn completed a deal on Dec 19 ’23 to sell 11000.0 shares. Meanwhile, Binder Gwendolyn sold 11000.0 shares on Nov 20 ’23.
